（原标题：2025年越南肉桂出口达3亿美元） 就出口市场来看，印度仍然是越南肉桂最大出口市场。2025年，越南肉桂对印度出口达45,184吨， 同比增长25.9%，市场份额为37.6%。紧随其后分别为美国（13,583吨）和孟加拉国（10,202吨）。 此外，2025年越南肉桂进口量为5034吨，进口额1130万美元，进口量同比增长11.7%，进口额同比 增长4.3%。进口来源国主要为印度尼西亚和中国。 《税务、海关在线》1月8日报道，根据越南胡椒香料协会（VPSA）统计，2025年越南肉桂出口总 量120,295吨，价值3.002亿美元，出口量同比增长20.4%，出口额同比增长9.4%。这是越南肉桂出口史 上最高水平，巩固了越南肉桂在全球香料市场的地位。 ...

来源：农民日报客户端 "广西生态优势金不换"——习近平总书记殷切嘱托，如同一颗绿色的种子，深植于祖国南疆的山水之 间。 难以想象，林海茫茫、绿浪翻涌的广西曾经薪柴难以为继，1950年森林覆盖率约为16%，木材产量仅为 1.6多万立方米。而如今八桂皆绿，森林覆盖率跃升至60%以上，木材年产量达到4200万立方米。更令 人惊叹的是，广西以约占全国5%的林地，生产出占全国近40%的木材，并在2024年成为全国首个林业 产业总产值突破万亿元的省份，用一场波澜壮阔的生态逆袭，生动诠释了"绿水青山就是金山银山"的深 刻内涵。 "我们始终牢记总书记嘱托，立足生态优势，将'两山'理念深度融入林草事业发展全过程。"广西壮族自 治区林业局党组成员、副局长李巧玉表示，一手抓"林"优生态，一手抓"业"促发展，坚定不移营造出绿 水青山，不断转化金山银山，广西探索出一条生态保护与经济发展辩证统一的兴林强桂之路。 筑牢产业根基的科技芯 桉树，这个生长迅速、一般5至8年便可成材的树种，是广西林业万亿产值的"当家树种"与"中坚力量"。 如果说桉树支撑了广西林业的"体量"，那么油茶则关乎着国家粮油安全的"质量"。普通的油茶没有香 味，但走进广西 ...

本报乌鲁木齐讯（全媒体记者 陈琼） 日前，兵团工信局公布第一批兵团工业设计创新中心认定名单， 新疆伊帕尔汗香料股份有限公司研创中心、新疆西部安兴电子材料有限责任公司工业设计创新中心、新 疆大全新能源股份有限公司工业设计创新中心入选。 兵团工信局相关负责人表示，将引导认定单位进一步加大设计研发资金投入，完善创新激励机制，集聚 优质设计资源，推动工业设计与实体经济深度融合，切实提升产品与服务的核心竞争力。同时，加强指 导服务与动态监管，通过充分发挥工业设计创新中心的示范引领作用，为兵团工业高质量发展注入源源 不断的动力。 据悉，此次兵团工业设计创新中心的认定，经过企业自主申报、师市工信部门推荐、专家评审、网上公 示及兵团工信局审议等程序，被认定的单位工业设计创新能力突出，体现了当前兵团工业设计领域的实 力与水准。 ...

每经AI快讯，华业香料（SZ 300886，收盘价：25.72元）12月18日晚间发布公告称，公司第五届第十一 次董事会会议于2025年12月18日在安徽省潜山市舒州大道42号安徽华业香料股份有限公司三楼会议室召 开。会议审议了《关于聘任高铭先生为公司副总经理的议案》等文件。 2024年1至12月份，华业香料的营业收入构成为：香料占比100.0%。 每经头条（nbdtoutiao）——海南封关政策红利全解析：零关税、低个税、投资准入放宽、跨境资金自 由、创业扶持…… （记者 曾健辉） 截至发稿，华业香料市值为19亿元。 ...

截至2025年6月末，公司资产负债率高达62.13%，短期借款及一年内到期负债高达3.4亿元，而账面货币 资金仅为9595万元。偿债压力之大，肉眼可见。 文 | 万 芙 近日，深交所官网显示，格林生物科技股份有限公司（下称"格林生物"）的创业板IPO申请已获受理。 这并不是格林生物第一次站在资本市场的门口。作为一家成立于1999年的老牌香料企业，这已是它第三 次向创业板发起冲击。 此前，格林生物分别于2020年和2023年两次递表，但均以"主动撤回"告终。第一次是因隐瞒环保处罚在 现场检查前"紧急撤单"，第二次则是在经历两轮问询后，因合规问题再度折戟。 如今，83岁的创始人陆文聪选择"卷土重来"，不仅将募资额大幅提升至6.9亿元，更在IPO前夕突击完成 了向女儿陆为的股权转让。然而，这份看似坚定的上市决心背后，却是格林生物挥之不去的合规阴影： 研发费用核算不准确、产能利用率持续下滑、环保处罚屡禁不止…… 一查就撤：合规漏洞成最大拦路虎 作为一家拟登陆创业板的高新技术企业，格林生物的研发成色也备受质疑。 数据显示，2022年至2025年上半年，公司研发费用率分别为2.34%、2.52%、2.73%和3.03%， ...

值得注意的是，沉香品牌在产区溯源和产品体验上也不断探索创新。以香至尊沉香为例，其创始人孙玉 辉始终坚持追根溯源的理念，深入星洲系主要产区，甄选当地优质野生原料。据行业人士了解，香至尊 沉香更注重线下体验，主张消费者通过实物接触沉香，感受其复杂香韵和天然油脂分布，这一做法也契 合了沉香收藏群体对真实产区和原生态产品的需求。 沉香本身是一种极为稀有的天然香料，其形成需经历漫长的自然过程，而星洲系产区的沉香以香气丰 富、层次分明著称。从市场角度来看，星洲系沉香因产量稀少、采集难度大，长期处于供不应求的状 态。近几年，随着沉香收藏逐渐成为高净值人群的兴趣领域，星洲系沉香的价格不断攀升，同时也引发 了对于产区真伪、品质鉴别等话题的热议。 行业观察人士指出，星洲系沉香的香韵和油脂分布往往较为均衡，香气中既有清雅又具醇厚，适合多种 品鉴方式。与此形成鲜明对比的是种植沉香，由于人工干预导致香气趋于单一，缺乏野生沉香的韵味和 收藏潜力。因此，在高端沉香市场中，星洲系野生沉香一直是收藏和鉴赏的核心对象。 近期，随着沉香市场热度持续升温，星洲系沉香产区正成为行业与收藏爱好者关注的焦点。所谓"星洲 系"，是指以东南亚一带为主的沉香原 ...

Core Insights - Xiamen Wanwei Spice Co., Ltd. has recently been established with a registered capital of 1 million RMB [1] - The legal representative of the company is Zhang Wanlin [1] - The company's business scope includes sales of forestry products, food additives, chemical products (excluding licensed chemical products), daily chemical products, specialized chemical products (excluding hazardous chemicals), machinery equipment sales, import and export of goods, technology import and export, and traditional spice products operation [1]

IPO Review and Registration Progress - Five companies passed the IPO review last week, including振石股份, 易思维, 爱得科技, 通领科技, and 兢强科技, with振石股份 planning to raise approximately 39.81 billion yuan [3][4] - 易思维 focuses on machine vision equipment for automotive manufacturing, reporting revenues of 20.4 million yuan and a net loss of 7.1755 million yuan for the first three quarters of 2025 [4] - Three companies passed the review at the North Exchange, with爱得科技 specializing in orthopedic medical devices, 通领科技 in automotive interior parts, and 兢强科技 in electromagnetic wire [5] Upcoming IPOs - Three companies, 永大股份, 美德乐, and 海菲曼, are set to present their IPO applications this week at the North Exchange [6] - 永大股份 reported revenues of 696 million yuan in 2022, with a projected decline in net profit for 2024 [6] - 美德乐's revenue from products in the new energy battery sector accounts for about 60% of its main business income, with high customer concentration [7] - 海菲曼 expects revenues between 232 million and 266 million yuan for 2025, with a net profit forecast of 70 million to 85 million yuan [7] New IPO Applications - Two IPO applications were accepted last week, with 北斗院 focusing on satellite navigation and space control technologies, and 格林生物 specializing in fragrance products [8][9] - 北斗院's revenue for 2025 is projected at 112 million yuan, with a declining gross margin trend [9] - 格林生物 aims to raise approximately 690 million yuan for various projects, including the production of high-end fragrances [9] New Stock Listings - Four new stocks were listed last week, with 大鹏工业 seeing a significant first-day increase of 1211.11% [11][13] - 海安集团 will officially list on November 25, with a share price of 48 yuan, reporting a revenue decline of 4.77% for the first three quarters of 2025 [12] - Other companies listed include 北矿检测, 恒坤新材, and 南网数字, all showing substantial first-day gains [13] Upcoming New Stock Subscriptions - Two new stocks are scheduled for subscription this week, with 摩尔线程 setting a record IPO price of 114.28 yuan per share [14] - 摩尔线程 expects to raise approximately 7.576 billion yuan, which would be a record for the year in the Sci-Tech Innovation Board [14] - 百奥赛图 anticipates a revenue of 1.351 billion yuan for 2025, reflecting a growth of 37.75% [16]

Core Viewpoint - Green Biological, a well-known company in the spice industry, has submitted its third IPO application to the Shenzhen Stock Exchange, which was accepted on November 21. The company has faced challenges in its previous attempts due to issues related to environmental compliance and profit warnings [1]. Group 1: IPO Journey - Green Biological's IPO journey has been tumultuous, with the first application in December 2020 being withdrawn due to failure to disclose environmental penalties and profit warnings. The second attempt in 2023 was also withdrawn after two rounds of inquiries, with the Shenzhen Stock Exchange focusing on environmental compliance and the company's positioning on the Growth Enterprise Market [1]. - The current IPO aims to raise 690 million yuan, with 420 million yuan allocated to a project for producing 6,300 tons of high-end spices, 120 million yuan for factory facility upgrades, 70 million yuan for R&D enhancements, and 80 million yuan for working capital [1]. Group 2: Company Overview - Established in December 1999, Green Biological is recognized as a "specialized, refined, distinctive, and innovative" enterprise in Zhejiang Province and ranks among the top ten companies in China's light industry spice sector. The company has undertaken four national torch plan projects and has been involved in drafting five national standards and 15 industry standards [1]. - The company specializes in the research and production of nearly 40 types of spice products, including turpentine, cedar oil, and fully synthetic series. Its core products are widely used in daily chemical fragrance formulations, covering household cleaning and personal care products [2]. Group 3: Financial Performance - From 2022 to 2024, the company's revenue is projected to grow from 631 million yuan to 961 million yuan, while net profit is expected to rise from 68.14 million yuan to 150 million yuan. The compound annual growth rates for revenue and net profit over the last three years are 23.35% and 48.59%, respectively. In the first half of 2025, revenue and net profit were reported at 548 million yuan and 94.58 million yuan, respectively [2]. - The company maintains a high export ratio, with over 85% of sales coming from international markets, primarily in Europe and North America. The top five customers account for more than 40% of total revenue [2]. Group 4: Shareholding Structure - The shareholding structure of Green Biological is notable, with the 83-year-old founder and chairman, Lu Wencong, holding 27.11% of the shares. His daughter, Lu Wei, who is also a director and deputy general manager, holds 9%, and together they control 36.11% of the shares. Lu Wei's shares were transferred to her from Lu Wencong in June 2025 [3]. - Prior to the IPO, the top ten individual shareholders are all company executives or former employees, with the core management team holding over 57% of the shares. This governance structure raises questions about the independence and decision-making mechanisms within the company [3].

Core Viewpoint - Green Biological Technology Co., Ltd. is making a third attempt to launch an IPO on the ChiNext board after two previous failures, with the latest application accepted by the Shenzhen Stock Exchange on November 21 [1] Group 1: Company Overview - Green Biological has focused on the research, production, and sales of fragrance products since its establishment [1] - The company aims to raise approximately 690 million yuan through this IPO, which will be allocated to various projects including a 6,300-ton high-end fragrance production project, smart factory upgrades, R&D innovation, and working capital [1] Group 2: IPO History - The company’s first IPO attempt was accepted in December 2020 but was withdrawn in February 2021 [1] - After a gap of over two years, the second attempt was made in June 2023, which was also accepted but was withdrawn again in September 2024 after more than a year of processing [1]